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Abstract 
 The development of immunosensors for the detection of small molecules 
is of great interest because of their simplicity, high sensitivity and extended 
analytical range. Due to their size, small compounds cannot be simultaneously 
recognized by two antibodies impeding their detection by noncompetitive two-
site immunoassays, which are superior to competitive ones in terms of 
sensitivity, kinetics, and working range. In this work, we combine the 
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advantages of magneto-electrochemical immunosensors with the improved 
sensitivity and direct proportional signal of noncompetitive immunoassays to 
develop a new Phage Anti-Immunocomplex Electrochemical Immunosensor 
(PhAIEI) for the detection of the herbicide atrazine. The noncompetitive assay is 
based on the use of recombinant M13 phage particles bearing a peptide that 
specifically recognizes the immunocomplex of atrazine with an anti-atrazine 
monoclonal antibody. The PhAIEI performed with a limit of detection (LOD) of 
0.2 pg mL-1, which is 200-fold better than the LOD obtained using the same 
antibody in an optimized conventional competitive ELISA, with a large increase 
in working range. The developed PhAIEI was successfully used to assay 
undiluted river water samples with no pretreatment and excellent recoveries. 
Apart from the first demonstration of the benefits of integrating phage anti-
immunocomplex particles into electrochemical immunosensors, the extremely 
low and environmentally relevant detection limits of atrazine attained with the 
PhAIEIS may have direct applicability to fast and sensitive detection of this 
herbicide in the environment. 
Keywords: Anti-immunocomplex peptide, Immunosensor, Atrazine, 
Chronoamperometry 
1. Introduction 
 The enzyme immunoassay with electrochemical detection, which 
combines the selectivity of antibodies with the sensitivity of electrochemical 
techniques, has become a powerful tool for the analysis of clinical, 
environmental, food and commodity samples, showing a high sensitivity and 
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extended analytical range (Han et al. 2013; Lou et al. 2013). Electrochemical 
techniques are particularly suited for rapid and direct detection of antibody–
antigen interactions, which adds to the advantageous high specificity of 
antibodies making possible to eliminate or simplify the sample cleanup, making 
the assay rapid and cost-effective. 
 The need for simple, rapid, reliable and economic detection of small 
molecules such as pesticides, mycotoxins, drugs and hormones in 
environmental and biomedical analysis is growing. The central component of 
these assays is the analyte-antibody reaction. If the analyte is a macromolecule, 
typically it is first captured by a primary antibody and then detected with a 
secondary antibody coupled to a tracer. This two-site format allows the use of 
excess concentrations of reacting antibodies, which taking into consideration 
the law of mass action, promotes the formation of the trivalent immunocomplex, 
even in the presence of trace amounts of the analyte (high assay sensitivity). In 
the case of immunoassays for small molecules, which usually have a single 
epitope, after the antigen-antibody interaction takes place up to 85% of the 
antigen surface is buried in the paratope of the antibody (Lamminmaki and 
Kankare 2001; Monnet et al. 2002) precluding a possible interaction with a 
second antibody (Jackson and Ekins, 1986). This rules out the use of two-site 
assays, and for this reason, small molecules are detected in an indirect way 
(competitive immunoassays) in which the analyte competes for binding to the 
detecting antibody with a tracer compound. In this format, the presence of the 
analyte is registered as a loss in signal (Deshpande, 1996) and limiting amounts 
of both antibody and tracer have to be used to obtain measurable inhibition with 
4 
 
trace concentrations of the analyte. The use of limiting concentration of 
reactants is unfavorable for the formation of the immunocomplex and hence, the 
sensitivity obtained with this format is inferior to that achieved with 
noncompetitive ones (Jackson and Ekins, 1986).  
 Noncompetitive immunoassays for the detection of small molecules can 
be developed by using short peptide loops that specifically react with the 
exposed region of the hapten and the conformational changes caused by its 
binding (Gonzalez-Techera et al. 2007b). These peptides are isolated from 
phage display peptide libraries that contain a vast repertoire of peptidic 
sequences (typically around 1x109-10 individual clones) expressed on the 
surface of the filamentous phage M13 of the fd family (Scott and Smith, 1990). 
Phage libraries are enriched for specific clones by repetitive rounds of affinity 
selection (biopanning), which includes binding to the desired selector molecule, 
washing and elution, reinfection of bacteria, and growth to amplify the selected 
phages. Once selected, the phage can be easily produced in large amounts in 
an inexpensive way, and perform as robust reagent, that can withstand harsh 
conditions of pH 2-12, up to 70°C and denaturants. We have previously shown 
that  phages bearing anti-immunocomplex peptides can be isolated from 
libraries and used as recognition agents for small molecules-antibodies 
complexes, in an ELISA format called phage anti-immunocomplex assay 
(PHAIA) (Gonzalez-Techera et al. 2007a; Gonzalez-Techera et al. 2007b; 
Rossotti et al. 2010). This strategy can be used to “convert” almost any 
competitive ELISA into a noncompetitive one, which usually performs with at 
least a 10-fold improvement in sensitivity. However, thus far, the potential of 
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PHAIA has not been explored in other formats, such as electrochemical 
immunosensors, despite the fact that the phage particles have shown 
advantageous properties for such applications (Arévalo et al. 2012). 
 On the other hand, for the immunosensors development the 
immobilization of the antibodies onto the solid surface is a key step that 
determines the stability, reproducibility and sensibility of the measured signal 
(Cosnier, 1999). The use of magnetics beads (MBs) coated covalently with 
Protein G confers specific binding and orientation of the captured antibodies 
(Margni, 1996; Liang et al. 2008), with additional advantages of easy handling 
and high reaction kinetics (Lin et al. 2007; Font et al. 2008). 
In this work we report the use of noncompetitive phage anti-
immunocomplex assay, in combination with a magneto-electrochemical 
immunosensor, for the detection and quantification of atrazine. The original 
immunoassay, which already exhibited a very high sensitivity in a competitive 
chemical hapten based format (LOD = 0.18 ng mL-1) (Giersch et al. 1993) 
showed an improvement in sensitivity of approximately 10-fold  when performed 
as PHAIA with the same antibody in a colorimetric ELISA (Gonzalez-Techera et 
al. 2007b). Atrazine (MW = 215 g mol-1) is a herbicide of the "triazines" family, 
that is usually applied to soil as pre-emergence after crop planting (Park et al. 
2014) with systemic and residual action. Atrazine is one of the most heavily 
used herbicides worldwide and it has been identified as an endocrine disrupting 
chemical and a potential carcinogen. For these reasons the development of 
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highly sensitive detection and quantification techniques to assess water quality 
are needed (Tao and Tang, 2004).  
Using the atrazine specific monoclonal antibody (MoAb K4e7) (Giersch et 
al. 1993), and phage particles bearing a short peptide loop (13A clone) that 
specifically recognizes MoAb K4e7-atrazine immunocomplexes, a Phage Anti-
Immunocomplex Electrochemical Immunosensor (PhAIEI) was developed. The 
PhAIEI uses MBs functionalized with protein G as solid phase for the MoAb 
K4e7-atrazine-phage reaction, an anti-M13 monoclonal antibody coupled to 
horseradish peroxidase (HRP) for phage detection. Hydrogen peroxide and 
pyrocatechol were used as enzymatic substrate and redox mediator, 
respectively. The benzoquinone produced by the enzymatic reaction was then 
detected on a carbon screen printed-electrode (CSPE) by chronoamperometry 
(CA). We found a remarkable increase in sensitivity with regard to the standard 
noncompetitive immunoassay ELISA with a significant time reduction of the 
assay. 
 
2. Material and methods 
2.1. Chemicals, antibodies and other reagents 
 All reagents used were of analytical grade. Atrazine was a gift from Dr. 
Shirley Gee, and anti-atrazine mouse monoclonal antibody (MoAb) K4e7 was a 
gift from Dr. T. Giersch (Giersch et al. 1993). Anti-M13 phage monoclonal 
antibody conjugated to horseradish peroxidase ( -M13-HRP) was purchased 
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from Pharmacia (Uppsala). Pyrocatechol (H2Q), 3,3-,5,5-tetramethylbenzidine 
(TMB) and bovine serum albumin (BSA) were obtained from Sigma–Aldrich. 
Dimethylsulfoxide (DMSO) and H2O (HPLC grade) were purchased from 
Sintorgan. The following buffer solutions were prepared from their salts (Merck, 
p.a.): 1 x 10−2 M KH2PO4 + Na2HPO4, 0.137 M NaCl and 2.70 x 10
−3 M KCl, pH 
7.0 (phosphate buffer solution, PBS); 5 x 10−2 M Na3C3H5O (COO)3 + 5 x 10
−2 
M Na2HPO4, pH 5.00 (citrate buffer solution, CBS); 5 x 10
−2 M Na3C4H5O4 + 5 x 
10−2 M NaC2H3O2 (acetate buffer solution), pH 5.5 and PBS containing 0.05% 
Tween 20 (PBST). H2O2, MgSO4 and H2SO4 were Merck p.a. Water samples 
were obtained by collecting surface water from the Rio Cuarto river, Rio Cuarto, 
Argentina, and were spiked with different amounts of atrazine. 
2.2. Materials and apparatus 
 The CSPE based on a disk shape working (1.5 mm of dia.) and ring 
shape counter electrodes of carbon and a pseudo-reference electrode of silver 
were purchased from Palm Sens. Magnetics beads modified with protein G 
(MBs) were Dinabeads® (Invitrogen). These MBs (2.8 m diameter) have a 
high binding capacity, approximately 8 g human IgG per mg of MBs. Before 
use, the MBs were washed with PBS and loaded with saturating amounts of 
MoAb K4e7 as described below. Nunc Maxisorp plates (96 well) were 
purchased from Nunc. A neodymium high field magnet was used for 
separations. Chronoamperometry (CA) measurements were performed with an 
AutoLab PGSTAT30 potentiostat, run with the GPES (version 4.9) 
electrochemical analysis software from Eco-chemie, Utrecht, The Netherlands. 
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Colorimetric measurements were performed with a Multiskan EX ELISA reader. 
The samples with MBs were mixed with a Vortemixer Speed Knob vortex. All 
steps of immunoassay were performed at 37 °C using a stove NEO LINE 
thermostat, Argentina. 
  
2.3. Preparation of stabilized phage suspensions 
 The amplified phage clone 13 A which bears the anti-immunocomplex 
peptide sequence CTPVRWFDMC, specific for the MoAb K4e7-atrazine 
complex was obtained as described previously (Gonzalez-Techera et al. 
2007b). After two steps of precipitation with PEG-NaCl, the phage particles 
were suspended in 1:50 volume of the original culture volume in PBS, which 
was supplemented with the Complete Protease Inhibitor Cocktail of Roche 
Diagnostics and 0.05% sodium azide. The preparations were filtered through a 
0.22 m filter and stored in aliquots at 4 °C. The phage suspension was titrated 
in ARI 292 E.coli cells, and the final phage concentration was 1 x 1012 phage 
particles mL -1. 
2.4. Checkerboard titrations for the development of sensitive standard 
microtiter plate-based ELISA for atrazine detection 
 Optimization of MoAb K4e7 and phage particles concentrations were 
performed on a 96-well high binding microtiter plate. ELISA plates were coated 
with 50 L of MoAb K4e7 in concentrations of 10, 5 and 2.5 g mL-1 (two rows 
for each concentration). After incubating for 1 h at room temperature the wells 
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were washed with PBS and blocked with 1% (w/v) BSA in PBS for 1 h. Later, 
the wells were washed with PBST. Then, 50 L of a solution of atrazine (100 ng 
mL-1) was added to all wells and incubated for 1 h at room temperature. The 
wells were washed with PBST and two-fold serial dilutions of phage particles, 
starting at a 1:10 dilution (1 x 1011 phage particles mL-1), then added to columns 
1–11 and incubated for 1 h at room temperature. Wells were washed with PBST 
and 50 L of a 1:5000 dilution of a MoAb -M13-HRP in PBST was added to 
each well. After 1 h, the plates were washed with PBST and 50 L of the HRP 
substrate (0.4 mL of a 6 mg mL−1 DMSO solution of TMB and 0.1 mL of 1% 
H2O2 in water in a total of 25 mL of 0.1 M citrate-acetate buffer, pH 5.50) was 
dispensed into each well. The enzymatic reaction was stopped after 15 min by 
the addition of 50 L of 2 M H2SO4, and the absorbance was measured at 450 
nm (corrected at 600 nm). 
2.5. Noncompetitive ELISA for atrazine determination 
 50 L per well of serial dilutions of atrazine standard in PBST were 
dispensed into microtiter plates coated with MoAb K4e7 and blocked with 1% 
(w/v) BSA in PBS. The wells were incubated for 1 h at room temperature. Later, 
the wells were washed with PBS, followed by addition of 50 L per well of an 
adequate dilution of the stabilized phage suspension. The MoAb k4e7 
concentration used for coating and the proper dilution of the phage suspension 
had been previously optimized by checkerboard experiments, as described 
above. After 1 h of incubation at room temperature, the wells were washed with 
PBST and 50 L of a 1:5000 dilution of MoAb -M13-HRP in PBST was added 
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to each well. After 1 h, the plates were washed with PBS. The development of 
color was obtained as previously described. 
2.6. Optimization of the components of the magneto-electrochemical 
immunosensor 
 The concentrations of MoAb K4e7, phage particles, H2O2 and H2Q and 
amount of MBs for the PhAIEI had to be optimized. The MBs were incubated 
with 50 L of a solution of MoAb K4e7, at final concentrations of 2.5, 5 and 10 
g mL-1. After incubating and stirring at 200 rpm for 30 min at 37 °C, the MoAb 
K4e7–MBs complexes were washed with PBS (a high magnetic field was used 
for separating the MBs from the solution). Then, a solution of 3% mouse serum 
(to prevent protein G capture of the generating signal antibody, the MoAb -
M13-HRP) was added, and incubated with stirring to 200 rpm for 30 min at 37 
°C. The MBs complexes were precipitated and washed with PBST. Later, 50 L 
of a solution of atrazine at 100 ng mL-1 was added to MBs and incubated with 
stirring for 30 min at 37°C. A magnetic separation and washing were then 
performed on MBs complexes with PBS and two-fold serial dilutions of phage 
particles, starting at a 1:10 dilution (1 x 1011 phage particles mL-1) an ending in 
1:640 dilution (1.5 x 108 phage particles mL-1), were added to the immune MBs 
and stirring at 200 rpm at 37 °C for 30 min. The MBs complexes were 
precipitated and washed with PBS and 50 L of a 1:5000 dilution of a MoAb -
M13-HRP in PBS was added, and the solution was stirred at 200 rpm at 37 °C 
for 30 min. The MBs complexes were washed and 25 L of a solution of H2Q in 
CBS was added and transferred to CSPE. Chronoamperometry was performed 
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as described below. The concentrations studied for the substrate and co-
substrate were varied from 1 x 10-3 mM to 5 mM. 
2.7. Noncompetitive phage anti-immunocomplex electrochemical 
immunosensor for atrazine quantitation 
 A heterogeneous noncompetitive immunoassay was used for the 
development of the atrazine PhAIEI. Briefly, suspensions of 1 L of MBs were 
transferred to Eppendorf tubes and washed three times with PBS, to remove 
the NaN3 used as preservative. Then, 50 L of MoAb K4e7 (10 g mL
-1 in PBS) 
was added and stirred at 200 rpm at 37 °C for 30 min to obtain MoAb K4e7–
MBs complexes. After incubation, a high magnetic field was used for separating 
the MBs loaded with the antibody. The MBs were washed with PBS and were 
incubated with 50 L of 3% (v/v) mouse serum in PBS for 30 min at 37 °C 
stirring at 200 rpm, in order to prevent direct binding of MoAb -M13-HRP to the 
remaining protein G binding sites. The MBs were then washed as described 
above, and re-suspended in 50 L of the atrazine standards or water samples, 
stirring to 200 rpm at 37 °C for 30 min. MBs were then magnetically separated, 
the supernatant was removed and MBs were washed with PBS. The MBs were 
re-suspended in 50 L of phage particles of clone 13A, in a dilution factor of 
1:40 (2.5 x 10 10 particles mL-1 ) in PBS, stirring to 200 rpm at 37 °C for 30 min. 
MBs were magnetically separated, the supernatant was removed and MBs were 
washed with PBS to remove non-specific bound phage particles. 50 L of  
MoAb -M13-HRP (dilution of 1:5000 in PBS) were added to MBs and stirred at 
200 rpm at 37 °C for 30 min. The MBs were washed with PBS and deposited 
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with the magnet. Then, the MBs were resuspended in 25 L of a solution of H2Q 
1.2 x 10-3 M, in CBS. The suspension was carried out on SPCE surface, and a 
potential of 0.2 V was applied. After 100 seconds (when the current value was 
constant), 5 L of a 6 x 10-3 M H2O2 solution was added to the SPCE surface 
(both final concentrations were 1 x 10-3 M). After 60 seconds the steady state 
current (I) was achieved. In the presence of H2O2, HRP catalyzes the oxidation 
of H2Q to Q (Ruan and Li, 2001) and its back electrochemical reduction to H2Q 
can be detected on the CSPE through chronoamperometry measuring the 
steady state current. The schematic representation of the PhAIEI is shown in 
Fig. 1. The steady state current obtained is proportional to the amount of HRP 
which in turn is proportional to the amount of atrazine.  
3. Results and discussion 
3.1. Microtiter plate based noncompetitive ELISA for atrazine 
determination 
 Checkerboard titration analysis was used to optimize both the amount of 
coating antibody and the final 13A clone phage concentration in the presence of 
a fixed amount of atrazine and in the absence of it, in order to set up the best 
conditions for noncompetitive ELISA colorimetric assay, as described in section 
2.4. A coating concentration of MoAb K4e7 of 10 g mL-1 produced the highest 
signal in combination  with a 1:160 dilution (which corresponds to 6.25 x 109 
phage particles mL-1) of stabilized stock phage suspension with a negligible 
signal in the absence of atrazine (Fig. S1, Supplementary material). Once the 
amount of antibody and final phage concentration were fixed, it was possible to 
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develop a noncompetitive colorimetric ELISA to measure the analyte-bound 
sites. The curve obtained is shown in Fig. 2, and is represented as binding 
percentage (B/B0 = absorbance value/absorbance value obtained for the 
saturation of atrazine) vs *atrazinec  (atrazine concentration) and was fitted to a four-
parameter logistic equation (Rodbard, 1974): 
*
50 AT
A D
y D
1 10exp((logSC logc )(Hill Slope))    (1) 
where A and D are the maximum and minimum B/B0 values, respectively, SC50 
is the concentration of atrazine which produces 50 % of signal saturation and 
Hill Slope is the slope at the midpoint of the sigmoid curve. The limit of detection 
(LOD) of the assay was calculated as the concentration of atrazine causing an 
increase in signal equal to three times the standard deviation of the blank (ACS, 
1980). The LOD was 0.040 ng mL-1 and the SC50 = 0.055 ng mL
-1. The 
calibration curve showed a linear range from 0.01 to 0.1 ng mL-1. These values 
are similar to those previously reported by us (Gonzalez-Techera et al. 2007b). 
3.2. Noncompetitive magneto-electrochemical immunosensor for 
atrazine determination 
Different parameters were studied to optimize the performance of the 
PhAIEI, including the concentration of MoAb K4e7, concentration of phage 
particles, the amount of MBs, volume and concentration of redox mediator and 
enzymatic substrate solutions and nonspecific adsorptions. It is know that the 
oxidation of H2Q to Q and the reduction of Q back to H2Q, is a quasi-reversible 
two-electron redox process (Forzani et al. 1997). Using CSPE this redox 
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process occurs with peak potential of 0.330 V for the oxidation of H2Q and 
0.138 V for the reduction of Q, when 1 x 10-3 M H2Q in CBS is used. H2O2 was 
not reduced in the potential range studied (Fig S2, Supplementary material). For 
the development of the PhAIEI assay, the potential chosen for all the 
experiments of Q reduction by chronoamperometry was 0.2 V. 
3.2.1. Optimization of the phage particles and MoAb K4e7 final 
concentrations for the PhAIEI assay development 
 As previously observed in the noncompetitive microtiter plate based 
ELISA, the best sensitivity is attained when the assay is performed with the 
highest concentration of phage particles and coating antibody that keeps a low 
background readout in the absence of analyte (Fig S1, Supplementary 
material). This was explored by varying the dilution factor of the phage particles 
between 1:10 and 1:1280, and capturing MoAb K4e7 from solutions with 
concentrations ranging from 2.5 to 10 g mL-1 (Section 2.6). The maximum 
amount of both phage particles bearing the anti-immunocomplex peptide 13A 
clone and MoAb K4e7 that could be used without generating a signal in the 
absence of atrazine was achieved at a 1:40 dilution (2.5 x 1010 phage particles 
mL-1) of the stabilized stock phage suspension and 10 g mL-1 of antibody, Fig. 
3.a. Also, a concentration of 2.5 x 1010 phage particles mL-1 in combination with 
MBs coated with 10 g mL-1 of MoAb K4e7 resulted in much clearer differential 
signals than the ones obtained with MBs coated with 2.5 and 5 g mL-1 when 
atrazine was present in a wide range of concentrations (1, 100 and 10 x 103 pg 
mL-1), as shown in chronoamperograms of Fig. 3.b. Therefore, a dilution factor 
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of phage particles of 1:40 (corresponding to 2.5 x 1010 phage particles mL-1) 
and a concentration of K4e7 MoAb of 10 g mL-1 were chosen for performing 
the following PhAIEI assays in optimal conditions. 
3.2.2. Optimization of the amount of magnetic beads used in the PhAIEI 
assay 
 The amount of MBs was varied from 7.5 to 60 g (0.25 to 2 L of MBs 
solution) in combination with MoAb K4e7 at a concentration of 10 g mL-1, a 
dilution factor of phage particles of 1:40 (corresponding to 2.5 x 1010 phage 
particles mL-1) and atrazine at a final concentration of 100 ng mL-1 (Fig. 4). The 
increase in the amount of MBs produced an increase in the current values 
reaching its maximum at 30 g of MBs, which was thus used for the 
development of the PhAIEI. The incubation time was also studied for each step 
of the immunoassay, and the current value increased up to 30 min, then it 
remained basically constant (data not shown). This value was used for each 
incubation step. 
3.2.3. Study of H2Q and H2O2 concentration and reaction volumes 
 Different concentrations of H2Q and H2O2 were explored (Section 2.6). 
Concentrations of H2Q were varied from 1 x 10
-5 M to 5 x 10-3 M with a H2O2 
solution of 1 x 10-3 M. An increase of current was observed with increasing H2Q 
concentration, Q was continuously produced and a steady state current was 
difficult to obtain. On the other hand, concentrations of H2O2 were varied from 1 
x 10-5 M to 5 x 10-3 M with a H2Q solution of 1 x 10
-3 M (Fig. S3, Supplementary 
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material). Again, an increase of current was obtained with increasing H2O2 
concentrations, but poor reproducibility was obtained for concentrations higher 
than 1 x 10-3 M of H2O2, and then, the concentrations of H2Q and H2O2 chosen 
were 1 x 10-3 M in both cases. Additionally, the reaction volume added to CSPE 
was also studied. The current value increases with volume reduction, due to an 
increment of concentration of enzymatically produced Q, and in this way, a 30 
L reaction volume was chosen. 
3.2.4. Calibration curve for atrazine using PhAIEI assay. 
A dose-response titration for atrazine was carried out in the concentration range 
1 x 10-3 to 1x 104 pg mL−1 (Fig. 5) using the PhAIEI. The calibration curve was 
plotted as binding percentage (B/B0 x 100) vs 
*
atrazinec , were B is the steady state 
current (I) obtained, and B0 is the steady state current (I0) obtained with analyte 
saturation. The calibration curve was fitted using Equation (1). The sensitivity 
(SC50) and LOD were 1.3 pg mL
−1 and 0.2 pg mL−1, respectively, with a Hill 
Slope of 0.75  0.12. This Hill Slope value agrees with the linear range of 
concentrations (0.2 pg mL-1 to 20 pg mL-1). The SC50 and LOD were 50-fold and 
200-fold better than those obtained for the colorimetric noncompetitive ELISA 
microtiter-plate-based immunoassay performed with the same antibody and 
anti-immunocomplex peptide borne phage. Various analytical electrochemical 
immunoassays have been described in the literature related to the 
determination of atrazine, with LODs that span a range from 6 pg mL-1 to 15 ng 
mL-1 (Zacco et al. 2006; Valera et al. 2007; Ionescu et al. 2010; Campanella et 
al. 2011; Giannetto et al. 2014; Liu et al. 2014). The sensitivity of the PHAIEI 
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presented here represents a 30-fold improvement in sensitivity compared to the 
most sensitive electrochemical based immunoassay reported for atrazine, to 
date (Zacco et al. 2006). The accuracy and reproducibility of the PhAIEI was 
checked using standard solutions of atrazine of 100 and 1 pg mL−1. The intra-
assay parameters were tested by performing three consecutive measurements 
of the same sample. These series of measurements were repeated for three 
consecutive days to estimate the inter-assay values. As summarized in Table 1, 
the PhAIEI assay for atrazine showed a very good accuracy and reproducibility. 
Cross-reactivity with related compounds was not performed in this work. 
However, this was previously done using the same MoAb and anti-
immunocomplex peptide in our initial work describing PHAIA (Gonzalez-
Techera et al. 2007b). In this work, cross-reactivity studies with: simazine, 
propazine, cyanazine, ametryn, simetryn, prometryn, terbutryn and propazine 
were performed. Only propazine exhibited 116% cross-reactivity with the 
chemical hapten and 144% with peptide clone 13A). We expect that the cross-
reactivity with triazines compounds to remain the same as those previously 
obtained in standard colorimetric microtiter noncompetitive ELISA.  
3.3. Atrazine determination in river water samples using the PhAIEI 
assay 
 The performance of the PhAIEI assay with real samples was tested using 
undiluted river water samples obtained from the Río Cuarto River, Córdoba, 
Argentina. Preliminary analysis of non-spiked river samples showed zero 
readings when analyzed by ELISA or PhAIEI (data not shown). Then, atrazine 
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was spiked with 100 and 1 pg mL−1 and each sample was analyzed in 
triplicates. Excellent recoveries of 99  6.8 % and 96  5.7 % were obtained for 
both samples, respectively. These results demonstrate that the PhAIEI has a 
high potential for ultra-sensitive water analysis even when undiluted samples 
are used.  
4. Conclusions 
 We recently described the use of phage particles for the development of 
ultra-sensitive competitive electrochemical sensor for the herbicide molinate 
(187 g mol-1), using analytes peptidomimetics (Arévalo et al. 2012). The 
filamentous nature of the fd phage proved to be of great importance for 
electrochemical detection. Over 2500 copies of the pVIII phage coat protein are 
expressed on the virion particle; since pVIII is the target epitope of MoAb -
M13-HRP, a large number of HRP molecules are bound to each phage 
providing a strong activity for pycocatechol oxidation in hydrogen peroxide 
presence. In this new development, this advantageous feature of the phage was 
combined with the improved sensitivity afforded by the use of anti-
immunocomplex peptides to generate an ultrasensitive immunosensor for non-
competitive electrochemical detection of atrazine, one of the most heavily used 
herbicides worldwide. As a result, the LOD of the PhAIEI (0.2 pg mL-1) was 900 
fold better than the LOD (180 pg mL-1) obtained with the same antibody in a 
conventional chemical hapten format (Giersch et al. 1993). The assay 
adaptation into the electrochemical format also improved with regard to PHAIA 
providing a 200 fold improve in sensitivity (LOD = 40 pg mL-1) with a 10-fold 
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extended linear dose-response range. The PhAIEI showed excellent results for 
atrazine determination in untreated river samples. Given that anti-
immunocomplex peptides can be isolated in a straightforward manner from 
phage display libraries resulting in noncompetitive assays with improved 
sensitivity, the development of PhAIEI assays stands as a salient option to 
boost the sensitivity of current electrochemical competitive immunosensors for 
the detection of small molecules. 
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Figure Captions: 
Figure 1. Schematic representation of the phage anti-immunocomplex 
electrochemical immunosensor (PhAIEI) for atrazine. Left panel: immunoassay 
components. Right panel: schematic representation of the electrochemical 
reduction involving the enzymatic process among pyrocatechol (H2Q), 
benzoquinone (Q), hydrogen peroxide (H2O2), and MoAb -M13-HRP 
conjugate. 
Figure 2. Noncompetitive colorimetric calibration ELISA for atrazine using 
phage particles. ELISA microtiter plates coated with 10 g mL-1 of MoAb K4e7 
and a dilution of 1:160 from the original stabilized stock phage suspension (6.25 
x 109 mL-1 phage particles) per well were used. Each point is the average of 
three replicates. 
Figure 3. Adjustment of different parameters for developing PhAIEI assay 
in optimal conditions. a) Effect of the dilution factor of phage particles on the 
binding of phage borne clone 13A peptide to MoAb K4e7-MBs complexes in the 
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presence ( ) or absence (■) of 100 ng mL-1 of atrazine. The MoAb K4e7 was 
captured on the MBs at a concentration of 10 g mL-1 and 30 g, respectively. 
Each point is the average of two replicated measurements. b) 
Chronoamperograms of 1 x 10−3 M H2Q and 1 x 10
−3 M H2O2 in CBS solution 
for three different MoAb K4e7 concentrations: I) 2.5 g mL-1, II) 5 g mL-1 and 
III) 10 g mL-1. The concentrations of atrazine used were: 1) 1 pg mL-1, 2) 100 
pg mL-1 and 3) 10 x103 pg mL-1. A dilution factor of the stabilized stock phage 
suspension of 1:40 (2.5 x 1010 phage particles mL-1) and 30 g of MBs were 
used. 
Figure 4. Effect of the amount of MBs used on the current obtained. An 
atrazine concentration of 100 ng mL-1 and MoAb K4e7-coated MBs at a 
concentration of 10 g mL-1 were used. The dilution factor of phage-borne anti-
immunocomplex peptide suspension used was 1:40 (which corresponds to 2.5 x 
1010 phage particles mL-1). Each point is the average of three replicated 
measurements. 
Figure 5. Calibration curve obtained with the PhAIEI assay for atrazine. 
Curve parameters for the noncompetitive assay were as follows: SC50 = 1.3 pg 
mL−1, LOD = 0.2 pg mL-1, Hill Slope: 0.7  0.1, correlation coefficient for the 
adjusted equation, R = 0.985. Each point is the average of three replicated 
measurements. Chronoamperograms recorded for different atrazine 
concentrations of the calibration curve are shown in the insert of the figure.  
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Table 1. Accuracy and reproducibility of the atrazine PhAIEI assay  
Atrazine concentration (pg mL
-1
) 
Intra-assay Inter-assay 
Mean %VC Mean %VC 
100 96 7.1 91 8.3 
1 0.92 6.3 0.91 6.9 
 
Highlights: 
 
We introduce phage particles bearing peptides that recognize an immunocomplex.  
We developed a magneto-electrochemical immunosensor for the herbicide atrazine. 
Screen printed electrodes are used as electrochemical transducers.  
Phage-borne can contribute to the development of ultrasensitive biosensors.  
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